Kawasaki Disease and Toxic Shock Syndrome—At Last the Etiology is Clear?
The Gram-positive bacteria S. aureus and group A streptococci (GAS) are common causes of colonization or infection. Diseases associated with S. aureus infection range from superficial skin infections, such as impetigo and furuncles, at one end of the spectrum to pyogenic abscesses, endocarditis, bone and joint infection, and toxic shock syndrome (TSS) at the other extreme. Similarly, infection with GAS ranges from pharyngitis to streptococcal toxic shock-like syndrome (TSLS) (Cunningham, 2000).
KeywordsKawasaki Disease Kawasaki Disease Patient Versus Beta Kawasaki Syndrome Streptococcal Toxic Shock Syndrome
Unable to display preview. Download preview PDF.
- De Inocencio, J. and Hirsch, R. (1995). Evidence for superantigen mediated process in Kawasaki disease. Arch. Dis. Child. 73(3), 275–276.Google Scholar
- Kaul, R., McGeer, A., Norrby-Teglund, A., Kotb, M., Schwartz, B., O’Rourke, K. et al. (1999). Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome—a comparative observational study. The Canadian Streptococcal Study Group. Clin. Infect. Dis. 28(4), 800–807.PubMedCrossRefGoogle Scholar
- Leung, D.Y., Sullivan, K.E., Brown-Whitehorn, T.F., Fehringer, A.P., Allen, S., Finkel, T.H. et al. (1997). Association of toxic shock syndrome toxin-secreting and exfoliative toxin-secreting Staphylococcus aureus with Kawasaki syndrome complicated by coronary artery disease. Pediatr. Res. 42(3), 268–272.PubMedCrossRefGoogle Scholar
- Sakaguchi, M., Kato, H., Nishiyori, A., Sagawa, K., and Itoh, K. (1995). Characterization of CD4+ T helper cells in patients with Kawasaki disease (KD): Preferential production of tumour necrosis factor-alpha (TNF-alpha) by V beta 2-or V beta 8-CD4+ T helper cells. Clin. Exp. Immunol. 99(2), 276–282.PubMedCrossRefGoogle Scholar